Ascendis Pharma A/S
F:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
O
|
Olin Corp
SWB:OLN
|
US |
|
Viel et Compagnie SA
PAR:VIL
|
FR |
|
Cerestar Indonesia Tbk PT
IDX:TRGU
|
ID |
|
A
|
Amata Corporation PCL
SET:AMATA
|
TH |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for A71 is 268.43 EUR with a low forecast of 226.58 EUR and a high forecast of 334.79 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
268.43
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 268.43 EUR with a low forecast of 226.58 EUR and a high forecast of 334.79 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
24%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
25%
The compound annual growth rate for Gross Profit over the next 8 years is 25%.
